Matrix metalloproteinase-9 (MMP-9) in allergic nasal polyps

Acta Histochemica

Volumn 112, Issue 1, 2010, Pages 92-95

  Bugdayci, Guler ^a   Kaymakci, Mustafa ^b   Bukan, Neslihan ^c  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b Doruk Medical Center   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

Edema; Human; Inflammation; Matrix metalloproteinase 9; Nasal mucosa; Nasal polyp

Indexed keywords

GELATINASE B;

ADULT; ALLERGIC DISEASE; ALLERGIC REACTION; ARTICLE; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EXTRACELLULAR MATRIX; FEMALE; HUMAN; INFLAMMATORY CELL; MALE; NOSE MUCOSA; NOSE POLYP; PATHOGENESIS;

ADULT; CHEMILUMINESCENT MEASUREMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS;

EID: 73749085803     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2008.07.002     Document Type: Article

References (20)

1. Bachert C., Gevaert P., Holtapples G., Cuvelier C., and van Cauwenberg P. Nasal polyposis: from cytokines to growth. Am J Rhinol 14 (2000) 279-290
2. Belleguic C., Corbel M., Germain N., Lena H., Baichot E., Delaval P.H., et al. Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 32 (2002) 217-223
3. Bhandari A., Takeuchi K., Suzuki S., Harada T., Hayashi S., Imanaka-Yoshida K., et al. Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol 124 (2004) 1165-1170
4. Blankenberg S., Rupprecht H.J., Poirier O., Bickell C., Smieja M., Hafner G., et al. Plasma concentrations and genetic variation of matrix metalloproteinase-9 and prognosis of patients with cardiovascular disease. Circulation 107 (2003) 1579-1585
5. Chen Y.S., Langhammer T., Westhofen M., and Lorenzen J. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy 62 (2007) 66-72
6. Ganter K., Deichmann K.A., and Heinzmann A. Association study of polymorphisms within matrix metalloproteinase-9 with bronchial asthma. Int J Immunogenet 32 (2005) 233-236
7. Harada H., Furuya M., Ishikura H., Shindo J., Koyanag T., and Yoshiki T. Expression of matrix metalloproteinases in the fluids of renal cystic lesions. J Urol 168 (2002) 19-22
8. Holzheimer R.G., and Steinmetz W. Local and systemic concentrations of pro- and anti-inflammatory cytokines in human wounds. Eur J Med Res 18 (2000) 347-355
9. Kostamo K., Tervahartiala T., Sorsa T., Richardson M., and Toskala E. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope 117 (2007) 638-643
10. Lechapt-Zalcman E., Coste A., d'Ortho M.P., Frisdal E., Harf A., Lafuma C., et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 193 (2001) 233-241
11. Lindholt J.S., Vammen S., Fasting H., Henneberg E.W., and Heickendorff L. The plasma level of matrix metalloproteinase-9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 20 (2000) 281-285
12. Mautino G., Oliver N., Chanes P., Bousquet J., and Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 17 (1997) 583-591
13. Molica S., Vitelli G., Levato D., Giannarelli D., Vacca A., Cuneo A., et al. Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early β-cell chronic lymphocytic leukemia. Eur J Haematol 70 (2003) 373-378
14. Montaner J., Molina C.A., Monasterio J., Abilleira S., Arenillas J.F., Ribo M., et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107 (2003) 598-603
15. Mygind N., Dahl R., and Bachert C. Nasal polyposis, eosinophil dominated inflammation and allergy. Thorax 55 Suppl. 2 (2000) S79-S83
16. Okada S., Kita H., George T.J., Gleich G.J., and Leiferman K.M. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 17 (1997) 519-528
17. Shimizu T., Kanai K., Asano K., Hisamitsu T., and Suzaki H. Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro. Mediators Inflamm 14 (2005) 150-159
18. Vignola A.M., Riccobono L., Profita M., Foresi A., Di Giorgi R., Guerrera D., et al. Effects of low doses of inhaled fluticasone propionate on inflammation and remodeling in persistent-mild asthma. Allergy 60 (2005) 1511-1517
19. Watelet J.B., Bachert C., Claeys C., and Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs. nasal polyposis. Allergy 59 (2004) 54-60
20. Watelet J.B., Demetter P., Claeys C., Van Cauwenberge P., Cuvelier C., and Bachert C. Neutrophil-derived metalloproteinase-9 predicts healing quality after sinus surgery. Laryngoscope 115 (2005) 56-61